Perphenazine Tablets

Form: Oral Tablets

Strength: 2 mg, 4 mg, 8 mg, 16 mg

Reference Brands: Trilafon®(US & EU)

Category: Antipsychotropic Drugs

Perphenazine tablets are FDA-approved in the United States for the treatment of schizophrenia and for the control of severe nausea and vomiting. In the EU, their availability varies by country under national procedures, primarily indicated for psychotic disorders. Regulatory requirements include GMP compliance, detailed clinical data on extrapyramidal side effects, and clear psychiatric risk labeling. U.S. submissions must follow FDA labeling guidelines and include pharmacovigilance plans. EU applications may require harmonization with national formularies. To explore dossier-ready Perphenazine tablets, alternative formulations, and global suppliers, visit Pharmatradz.com — your trusted B2B pharma sourcing platform.